Julia Sable
About Julia Sable
Julia Sable serves as the Director of CMC Project Management at Kite Pharma, having previously held similar positions at Tmunity Therapeutics and Legend Biotech. She possesses extensive experience in virology, regulatory authoring, and advanced imaging systems, supported by advanced degrees from Columbia University and Youngstown State University.
Work at Kite Pharma
Julia Sable currently serves as the Director of CMC Project Management at Kite Pharma, a position she has held since 2023. In this role, she is responsible for overseeing the development and management of Chemistry, Manufacturing, and Controls (CMC) processes. Her work is crucial in ensuring that Kite Pharma's products meet regulatory standards and are manufactured efficiently. Kite Pharma is known for its focus on cell therapy and innovative treatments for cancer.
Previous Experience at Tmunity Therapeutics
Before joining Kite Pharma, Julia Sable worked at Tmunity Therapeutics Incorporated as the Director of CMC Project Management from 2022 to 2023. During her tenure in Philadelphia, Pennsylvania, she managed CMC activities related to the development of Tmunity's therapeutic products. Her role involved coordinating various aspects of project management to ensure successful product development.
Education and Expertise
Julia Sable holds a Doctor of Philosophy (PhD) from Columbia University, where she also completed a Master of Philosophy (MPhil). She earned her Bachelor's of Science in Biology/Biological Sciences from Youngstown State University. Additionally, she has a Master of Science (MS) in Science Education from Teachers College, Columbia University. Her educational background supports her expertise in areas such as regulatory authoring, quality auditing, and continuous vector manufacturing.
Background in Research and Development
Julia Sable has extensive experience in research and development, having held various positions at Columbia University and other institutions. She served as the Director of Virology at Columbia University from 2016 to 2018 and was involved in managing laboratories focused on advanced imaging systems and viral tools. Her work at the Gene Therapy Program at the University of Pennsylvania as Director of the Pre-clinical Vector Core further solidified her expertise in vector development.
Skills and Specializations
Julia Sable possesses a range of skills relevant to her roles in project management and research. She is skilled in aseptic processing, supply chain and demand planning, and lean manufacturing standards. Her specialization includes working with AAV, Lenti, Retro, and Rabies platforms for neuroscience research. She emphasizes continuous improvement and performance enhancement in her work, contributing to the advancement of therapeutic technologies.